Prostate cancer is the most common cancer in Sweden and accounts for most cancer deaths among males in Sweden today. Despite the magnitude of this cancer, few risk factors have been identified to date. The most consistent risk factor so far has been a positive family history, as found in a number of case-control studies (1, 2) . In a recent cohort study of familial prostate cancer in Sweden, we found a 70 percent overall increased risk of developing prostate cancer among sons of men with the same disease, with higher relative risk in younger ages (3) .
In breast cancer, several different reports using segregation analysis support an autosomal dominant inheritance with a variable penetrance between 70 and 90 percent in gene carriers, at least in a subset of breast cancer cases (4, 5) . These results provided the logical platform for additional linkage studies resulting in the discovery of the two breast cancer genes BRCA1 and BRCA2 (6, 7) . In the first study of the nature of inheritance of prostate cancer (8) , a group from The Johns Hopkins University showed that the familial clustering of prostate cancer was best explained by an autosomal dominant gene, where a rare allele (q = 0.0030) results in early onset of prostate cancer. This high-risk allele was highly penetrant, with 88 percent of the gene carriers predicted to develop disease by the age of 85 years (8) . The 691 families used in that study were not selected for a positive family history; however, the probands represent a highly selected patient group with an early average age of diagnosis (59.3 years) and with only localized tumors suitable for radical prostatectomy. So far, the result from this segregation study has not been confirmed. In a recent cohort study from Los Angeles and Hawaii (9) , an excess of prostate cancer in men whose brothers were affected compared with those whose fathers were affected was consistent with the hypothesis of an Xlinked or recessive model of inheritance.
The aim of our study was to analyze the mode of inheritance of prostate cancer in an unselected large number of Swedish families. For this purpose, we used complex segregation analysis.
MATERIALS AND METHODS
A more detailed description of this selection procedure of the nuclear families can be found in an earlier report (3) and is summarized in figure 1 . Between 1959 and 1963, 8,515 men with prostate cancer were reported to the nationwide Swedish Cancer Register. In 2,768 of these cases (32.5 percent), histologic or cytologic verification was not obtained. These 2,768 diagnoses were based either on clinical observations or on radiographic examination and therefore were excluded due to uncertainty in diagnosis. The remaining 5,747 men (hence referred to as fathers) constitute the study base. In the local parish offices throughout Sweden, information concerning the nuclear family was recorded and stored. The number of children and the personal identification number of each child of the 5,747 fathers were obtained from the local parish offices. Due to inability in locating some of these fathers with prostate cancer or because no answer was received from the parish office, another 345 fathers (6.0 percent) were excluded. A total of 6,005 sons were linked to the 5,402 fathers. However, for 402 sons, the complete personal identification number (10 digits) was not obtained from the parish offices and thus could not be linked to the registries. Linkages were made to the Swedish Causes of Death Register and the National Population Register (which contained current residence) to find out whether the remaining sons were alive and currently living in Sweden. An additional 107 sons were not identified in either of these two registries and had to be excluded. These 107 sons either had died before 1952 or had emigrated from Sweden before 1990. The remaining 5,496 sons were linked to the nationwide Swedish Cancer Register to identify all sons with prostate cancer.
The probands in this study are the 2,857 fathers with at least one son identified, so 2,545 fathers without any sons were excluded from the segregation analysis. Among the 5,496 sons, 53 were younger than 38 years and were also excluded from analysis. None of the 53 sons were diagnosed with prostate cancer. A total of 304 of the 5,496 sons were identified with prostate cancer through the linkage with the Cancer Register. Only men diagnosed with prostate cancer were scored as affected, and the same criterion for affection status was used among both sons and fathers. As these nuclear families were ascertained through an affected father in a population-based registry, the probability of ascertainment was complete selection.
Complex segregation analysis was performed using the computer program POINTER (10) . In segregation analysis, it is incorrect to assume that the gene frequency is constant at all ages because any gene causing specific mortality must decrease with age. To take into account age-specific mortality, each individual was assigned to one of nine liability classes according to his age at ascertainment or diagnosis. The liability indicator was calculated as previously by Morton et al. (10) . For an individual who at last observation was in age class i, the risk of being affected is where Ij is the cumulative incidence to the midpoint of the age interval, and Mj _ i is the cumulative diseasespecific mortality to the end of the preceding age interval (11) . Data on cumulative incidence were derived from the Swedish Cancer Register. The incidence of prostate cancer has increased dramatically between 1958 and 1990 in Sweden (12) . Because all fathers were diagnosed between 1959 and 1963, and most of the sons were diagnosed between 1970 and 1990, two different cumulative incidences and corresponding morbid risks were calculated, respectively. The data on prostate cancer mortality were derived from the National Causes of Death Register. As the age-standardized mortality for prostate cancer has been almost constant in Sweden between 1959 and 1990, the average mortality from 1976 to 1985 was used for both fathers and sons. The cumulative incidences, mortalities, and morbid risks and the selection of liability classes are shown in table 1. When the morbid risk was combined from more then one age class, the average morbid risk was used. Mothers in the nuclear families were assigned to liability class 1.
Segregation analysis is designed to compare a series of models of inheritance to account for transmission of disease risk in families. Risk of disease in nuclear families is assumed to be due to a single major locus, a multifactorial component, or a mixture of both. The parameters estimated in segregation analysis include the following: the allele frequency (q) of the high-risk allele at the single major locus; a parameter representing dominance at the major locus (d), where d = 0 and the major gene is recessive, or d = 0.5 additive and d = 1 is dominant; the displacement between homozygotes at this locus is in standard deviation units (/); and multifactorial heritability (//) is as previously described by Morton et al. (10) . In the analysis, conditional likelihood was used to test competing hypoth- eses: Minus twice the log likelihood (2 lnL + C, where C is a constant) under the general model subtracted from a reduced model approximated a chi-square statistic with degrees of freedom equal to the number of parameters fixed in the reduced model.
RESULTS
The results from the segregation analysis for all families are given in table 2. This analysis gave strong evidence that familial clustering in prostate cancer is not due to chance (^4 = 106.98, p < 0.001). All models incorporating a major gene {q > 0) for genetic transmission gave a better fit to these data than the multifactorial model (^3 = 16.49, p < 0.001). However, much of the evidence came from one extreme family (family 2018), in which all four sons were affected with aggressive prostate cancer before the age of 60 and three of four daughters were affected with early onset breast cancer (figure 2). After excluding this extreme family, we reanalyzed the remaining 2,856 families (table 3) . Even after excluding family 2018, we found significant evidence for a major gene (X 2 = 7.96, p < 0.05). The dominant model gave the best fit among all single gene models and the log likelihood for the dominant models was not different from the generalized single locus model, inasmuch as the residual heritability component approached zero at the boundary. Under both models, the estimated gene frequency (q) was 0.0167, and displacement (t) between "high-risk" and "low-risk" genotypes was 1.30 in standard deviation units in the dominant model.
Taking the age-specific mortality into account, Iselius et al. (4) defined the penetrance in gene carriers (C) as the approximate cumulative incidence for gene carriers in the j\h liability class, given by the following:
where the genotype-specific mortality is
By this computation, penetrance is 0.23 at age 65 and lifetime penetrance is 0.63 for carriers of this putative high-risk allele ( figure 3) .
DISCUSSION
This segregation analysis confirms that the clustering of prostate cancer seen in some families can be explained by an autosomal dominant gene, which is consistent with the first report of Carter et al. (8) using segregation analysis in prostate cancer families. However, the lifetime penetrance (0.63 vs. 0.88) was lower and the gene frequency was significantly higher (0.0167 vs. 0.0030) in this Swedish study. These two study populations are very different, and there are many possible explanations for these discrepancies. It is also possible that multiple genes may be involved in the inheritance of this complex disease. One gene might be highly penetrant, and a rare gene might be causing a very early onset prostate cancer, e.g., family 2018 (figure 2). Other genes might be more common in the population but less penetrant as indicated by our analysis in which family 2018 was excluded. In the recently published linkage of hereditary prostate can- cer families to chromosome lq 24-25 {HPC1) (13) , this heterogeneity was confirmed as approximately one third of the studied families were linked to this region. In the parametric model of this linkage study (13) , the 63 percent lifetime penetrance derived from this present Swedish segregation analysis was used for unaffected males older than 75 years. There are substantial differences between these two segregation analyses concerning the selection of families. Our families constitute a large sample of nuclear families ascertained through an affected father from all over Sweden with no additional selection for a positive family history. Only registry data concerning prostate cancer diagnosis were used, so there is no information bias. Since the father always had prostate cancer and we had no data on the family history on the mother's side, we cannot address any issue of any maternally inherited prostate cancer. In the study by Carter et al. (8) , the family history of 691 probands with prostate cancer was used, with most of the information coming from fathers and brothers of the affected proband. The mean age of diagnosis of prostate cancer of these US probands was 59.3 years, and all were candidates for radical prostatectomy with only localized disease. Thus, this group of US probands was not representative for all prostate cancer.
In this study, we used POINTER in the segregation analysis, which allows for different liability classes for different ages of all persons being studied and incorporates incidence rates into the analysis of models of inheritance. The calculation of incidence and mortality rates was based on data from the Swedish Cancer Registry and the Causes of Death Registry, so estimation of morbid risk is exceptionally good in this study. In the segregation model used by Carter et al. (8) , no population data were available. Rather, the statistical model fit models of inheritance where different genotypes had different distributions for age of onset. In the final model, individuals carrying the putative high-risk allele had a mean age of onset 15-20 years earlier than noncarriers. In the regression model used, it was also assumed that all males developed prostate cancer, if they lived long enough. These assumptions may or may not be realistic for this disease, but how they affect the result of the segregation analysis is difficult to estimate.
It is likely that several genes are involved in determining risk for hereditary prostate cancer; however, that cannot be resolved any further in the segregation analysis we present here. Prostate cancer is also an etiologically complex disease with hereditary factors accounting only for 5-10 percent (14) . Therefore in multiplex families with prostate cancer, there are likely to be phenocopies, i.e., affected individuals who do not carry the high-risk allele. This might be a significant problem in linkage analysis since the ability to discriminate between the genetic and sporadic cases based on age of diagnosis alone is limited. In addition, there is no distinct clinical feature of hereditary cases yet described (15, 16) . This makes it more difficult to find prostate cancer genes in linkage analysis, compared with breast cancer or colon cancer.
In conclusion, the result of this study gives more evidence that a hereditary form of prostate cancer does exist and that it is transmitted in a dominate mode. It also confirms the result from one earlier published segregation analysis and provides the context for interpreting the recently published linkage of hereditary prostate cancer families to chromosome lq 24-25 (HPC1) (13) .
